Chris Larson’s Post

June saw major funding rounds in the payer/employer space. Here are the top five: 1) Sidecar Health - Raised $165M in Series D funding led by Koch Disruptive Technologies. Expanding into Florida. 2) Talkiatry - Secured $130M in Series C funding from Andreessen Horowitz to enhance value-based care and partnerships. 3) Sword Health - Obtained $130M to support virtual musculoskeletal care, offering liquidity to employees and early investors. 4) Pomelo Care - Raised $46M in Series B funding led by First Round Capital and a16z, aimed at expanding virtual maternal health services. 5) Humata Health - Garnered $25M led by Blue Venture Fund to enhance AI for streamlining prior authorization processes. #HealthcareFunding #PayerEmployer #DigitalHealth #Innovation #HealthcareTech

"Revolutionizing Senior Care: Zing Health's $140M Boost for Tailored Medicare Advantage" Zing Health secures major funding to expand special needs plans: 💰 $140 million raised from top healthcare investors 🚀 Among fastest-growing MA plans since 2023 🎯 Focus on chronic special needs plans for underserved seniors 🤝 Value-based care model aligning physicians and specialists 🏥 Addressing gap in MA market - only 2% of enrollees in chronic SNPs Zing Health: Redefining Medicare Advantage with personalized, tech-driven care for seniors with chronic conditions. The future of tailored healthcare is here.

🚨 Big News in Healthcare 🚨 Zing Health, a Chicago-based Medicare Advantage insurer, just raised $140M in new funding! 💰 Backed by Health2047 Capital Partners, CRG LP, First Trust Capital Partners, and existing investors Newlight Partners, Town Hall Ventures, Health2047, and Leavitt Equity Partners. This capital will help Zing Health expand its chronic special needs-focused plans to serve more beneficiaries. 👵🏻👴🏽 Why It Matters: • Zing Health is committed to providing personalized care tailored to members' specific health and social needs. 💡 • Led by CEO Andrew Clifton, they work with a broad network of high-quality providers to ensure better healthcare outcomes. 🏥 Co-founded in 2019 by Dr. Eric Whitaker and Garfield S Collins, Zing Health’s mission is to deliver value-based care and enhanced member experiences through technology and innovative product design. 📲 This funding will strengthen their platform, empowering them to make high-quality care more accessible to even more Medicare beneficiaries across the U.S. 🌍 Zing Health is transforming Medicare Advantage – are you keeping up? 🚀 📢 Stay tuned to Future Techly for the latest updates on this groundbreaking initiative and the latest in tech and business! 💥 Source: FinSMEs #HealthcareInnovation #MedicareAdvantage #ZingHealth #ChronicCare #PersonalizedCare #ValueBasedCare #HealthTech #FutureTechly

Elevance Health is creating a new #primarycare model that nudges their members to their owned clinics - essentially paying themselves ♻️ They’re partnering with a #privatequity firm, Clayton Dubilier & Rice (CDR), to create a #jointventure called Mosaic Health. What do we know: 🖼️ Mosaic is comprised of two of CDR’s portfolio companies, apree health (a digital navigation and clinical advocacy company formed when Vera Whole Health and Castlight Health merged) and Millennium Physician Group (a primary care platform serving 900 providers). 🧑⚕️ Elevance is following similar moves like their rivals, such as UnitedHealthcare, CVS Health, and Humana, all of which invested heavily in building out their #providernetworks, including through #acquisitions. 📈 Owning care sites will give these #payors more visibility into their members’ current and potential health conditions. This also diversify their revenue streams from their core businesses. 🧑🧑🧒🧒 They expect to treat 1M members across 19 states. Thoughts about #insurancecompanies being more involved in your health??

Zala Insurtech News: Yurtle, a London-based insurtech focused on alleviating caregiver burnout in workplaces, has successfully concluded a Seed funding round amounting to £1.37 million. The post Yurtle Raises £1.37 Million in Seed Funding to Address Caregiver Burnout appeared first on Insurtech Insights. Read on below >> #insurance #innovation #insurtech

Thinking about making a change and elevating your business to the next level? Take a few minutes to listen CareValue can offer you and then make the switch here: https://bit.ly/3LmaWoB. #MedicareInsurance #InsuranceAgents #FMO #CareerOpportunity #JoinUs

Over the past 18 months, I've assisted multiple insurers and hospital providers in preparing for negotiations, focusing particularly on managing the risks and processes related to terminations. Observing the recent termination between St Vincent's Hospitals and nib Health Fund, it's evident to me that St Vincent's has executed a well-planned strategy. They've chosen the right target at the opportune moment, suggesting long-term planning on their part. For those interested in my detailed analysis of this termination and St Vincent's handling of it, you can read my recent article at https://wix.to/Vecgl05. As hospitals continue to face viability concerns, unfortunately, events like this termination may become more commonplace rather than exceptional. While termination can be effective when part of a mature negotiation strategy, it can also be risky, costly, and ineffective if not executed properly. Investing in proper support to develop, implement, and manage negotiation strategies will often lead to positive outcomes without jeopardizing the long-term relationships between Health Funds and Hospitals. If you or your team need assistance in developing a negotiation strategy, please don't hesitate to reach out. #nib #StVincents #HospitalHealthFundTermination #PrivateHospitals

Humana is now an acquisition target...again. Cigna Healthcare is the potential acquirer. The acquisition rationale has strategic, operational and financial dimensions emanating from the healthcare insurance (payer) industry's specific -- dare I say, challenging -- characteristics. The payer industry is being buffeted by headwinds such as aging demographics and consequent high utilisation rates by patients on the one hand. Meanwhile, clients (including US Federal government and corporations) are negotiating harder than ever before on their member contracts on the other hand. In addition, there is the opportunistic dimension of Humana's stock price that is down disproportionately greater than it's industry peers (~40% this year alone). Earlier this month, I wrote about this exact scenario of Humana becoming an M&A target given its compelling valuation. You can read that post below here: https://lnkd.in/eENDRC7B At the time, Humana stock was trading at $230 per share. Today, the stock is trading at ~$265 per share -- and low and behold -- #Cigna is reportedly getting back into the fray to potentially acquire #Humana. Merger Arbitrage is one of our four core Alpha-generating strategies at #Neuron. In our view, Humana is one of the best Merger Arb opportunities of 2024. #neuron #neuronpartners #neuroninvestors #hedgehawk

Headway scores $100M, more than doubling its valuation to $2.3B - MobiHealthNews #Funding: Headway secures $100M in funding, doubling its valuation to $2.3B #Investors: Leading investors support Headway's growth #Expansion: Headway plans to expand its services and reach #Impact: How Headway's growth will impact the healthcare IT industry #Future: The future outlook for Headway in the healthcare IT market Headway, a healthcare IT company, has recently secured $100M in funding, which has doubled its valuation to $2.3B. Leading investors have supported Headway's growth, indicating confidence in the company's potential. With this funding, Headway plans to expand its services and reach, potentially revolutionizing the healthcare IT industry. The impact of ai.mediformatica.com #health #headway #funding #mentalhealth #platform #sparkcapital #accel #insurance #medicaid #medicare #a16z #billing #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3LBQtwg)

Clover Health is signaling a brighter future with strong first-quarter results and a revised outlook. Key takeaways: - Financial performance improves: Net loss narrowed significantly, adjusted EBITDA swung to a profit, and revenue grew year-over-year. - Full-year guidance raised: Clover is now projecting higher adjusted EBITDA, reflecting its confidence. - Focus on care management: The company emphasizes its Clover Assistant platform for chronic disease management as a key differentiator. - Strategic shift: Clover establishes a new affiliate to expand its non-clinical quality improvement services. - Share repurchase program: Up to $20 million will be used to buy back shares over the next two years. Learn more: https://hubs.ly/Q02wJwxD0